EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeit

Stereoelectroencephalography‐guided radiofrequency thermocoagulation for drug‐resistant epilepsy: A meta‐analysis

Pavel S Pichardo-Rojas iD, Diego Pichardo-Rojas iD, Carlos A Zarate-Duran, Amir Hjeala-Varas, Roberto Sanchez-Velez, Aldo Barrón-Lomelí, Mario Cesar Torres Chavez, Ernesto A Gutierrez Herrera, Oswaldo Torres-Madrid, Ahmed M Raslan, Ahmed Negida, Vanessa Milanese

Epilepsia · 2025-10 · 66 (10) · 3602-3620

DOI: 10.1111/epi.18524 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Epilepsia, online erschienen am 26.06.2025. Verfasst von Pavel S Pichardo-Rojas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Electrocoagulation, Electroencephalography, Stereotaxic Techniques. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In patients with focal drug‐resistant epilepsy (DRE), resective epilepsy surgery correlates with high rates of remission. However, in cases where the epileptic region is deemed surgically inaccessible, or when it involves a complex network, stereoelectroencephalography‐guided radiofrequency thermocoagulation (SEEG‐RFTC) might be an alternative therapeutic strategy. However, most of the available evidence is limited to small observational studies. An updated meta‐analysis is warranted to provide a comprehensive assessment of SEEG‐RFTC in patients with DRE.

Methods

Databases were searched until September 9, 2023 to identify published studies reporting on the effectiveness of SEEG‐RFTC in patients with DRE. The primary outcomes of interest were the 1‐year seizure‐freedom rate and response rate (50% seizure frequency decrease from baseline). These outcomes were pooled using the inverse variance and a random‐effects model.

Results

We screened 182 articles and included 16 retrospective cohort studies. A total of 437 unique patients from 12 nonoverlapping cohorts were analyzed for seizure and complication outcomes. The pooled seizure‐free rate after 1 year was 37.8% (95% confidence interval [CI] = 24.7%–50.8%), whereas the seizure response rate after 1 year was 69.7% (95% CI = 52.7%–86.7%). There was high heterogeneity among the included studies. Subgroup analysis revealed that patients with nodular heterotopia achieved higher rates of seizure freedom (57.1%, 95% CI = 38.8%–75.5%) compared to those with cortical dysplasia (CD) and magnetic resonance imaging‐negative conditions. Furthermore, hippocampal sclerosis patients exhibited higher seizure freedom rates (66.7%, 95% CI = 49.8%–83.5%) than those with CD (12.0%, 95% CI = .0%–24.7%). Significance SEEG‐RFTC might be an effective therapeutic option for seizure control in patients with DRE who undergo SEEG for DRE workup. The role of SEEG‐RFTC as a potential adjunct therapy to laser interstitial thermal therapy or surgical resection should be explored. This study highlights the need for well‐designed clinical trials to compare SEEG‐guided RFTC with other therapeutic modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyElectrocoagulationElectroencephalographyStereotaxic TechniquesHumansTreatment Outcome

Stichwörter der Autor:innen

SEEG‐guideddrug‐resistant epilepsyepilepsy surgeryradiofrequency thermocoagulationstereotactic

Autor:innen und Institutionen

  • Vivian L. Smith Department of Neurosurgery, University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA.
  • Latin American Neurosurgical Collaborative for Excellence in Research, Mexico City, Mexico.
  • Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City, Mexico.
  • University of Texas Health San Antonio, San Antonio, Texas, USA.
  • Universidad Católica Boliviana "San Pablo" Regional Santa Cruz, Santa Cruz, Bolivia.
  • Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador.

ORCID-Profile: Pavel S Pichardo-Rojas, Diego Pichardo-Rojas

Zitieren

APA

Pichardo-Rojas, P. S., Pichardo-Rojas, D., Zarate-Duran, C. A., Hjeala-Varas, A., Sanchez-Velez, R., Barrón-Lomelí, A., Chavez, M. C. T., Gutierrez Herrera, E. A., Torres-Madrid, O., Raslan, A. M., Negida, A., & Milanese, V. (2025). Stereoelectroencephalography‐guided radiofrequency thermocoagulation for drug‐resistant epilepsy: A meta‐analysis. Epilepsia, 66(10), 3602-3620. https://doi.org/10.1111/epi.18524

Vancouver

Pichardo-Rojas PS, Pichardo-Rojas D, Zarate-Duran CA, Hjeala-Varas A, Sanchez-Velez R, Barrón-Lomelí A, et al. Stereoelectroencephalography‐guided radiofrequency thermocoagulation for drug‐resistant epilepsy: A meta‐analysis. Epilepsia. 2025;66(10):3602-3620. doi:10.1111/epi.18524

BibTeX
@article{PichardoRojas2025,
  author = {Pichardo-Rojas, Pavel S and Pichardo-Rojas, Diego and Zarate-Duran, Carlos A and Hjeala-Varas, Amir and Sanchez-Velez, Roberto and Barrón-Lomelí, Aldo and Chavez, Mario Cesar Torres and Gutierrez Herrera, Ernesto A and Torres-Madrid, Oswaldo and Raslan, Ahmed M and Negida, Ahmed and Milanese, Vanessa},
  title = {Stereoelectroencephalography‐guided radiofrequency thermocoagulation for drug‐resistant epilepsy: A meta‐analysis},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {10},
  pages = {3602--3620},
  doi = {10.1111/epi.18524}
}
Kostenlos starten →